FF EAI Robotics Ecosystem, Inc. (FFR)
1.52
+0.02
(+1.33%)
USD |
NASDAQ |
Oct 13, 14:01
FF EAI Robotics Ecosystem Net Income (Quarterly) : -4.188M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.188M |
| March 31, 2026 | -6.079M |
| December 31, 2025 | -10.60M |
| September 30, 2025 | -2.038M |
| June 30, 2025 | -1.685M |
| March 31, 2025 | -2.646M |
| December 31, 2024 | -0.8558M |
| September 30, 2024 | -1.794M |
| June 30, 2024 | -1.477M |
| March 31, 2024 | -2.033M |
| December 31, 2023 | -2.468M |
| September 30, 2023 | -3.235M |
| June 30, 2023 | -3.537M |
| March 31, 2023 | -3.235M |
| December 31, 2022 | -3.599M |
| September 30, 2022 | -3.144M |
| June 30, 2022 | -4.128M |
| March 31, 2022 | -4.320M |
| December 31, 2021 | -6.061M |
| September 30, 2021 | -3.038M |
| June 30, 2021 | -5.398M |
| March 31, 2021 | -5.243M |
| September 30, 2020 | -8.113M |
| Date | Value |
|---|---|
| June 30, 2020 | -18.58M |
| March 31, 2020 | -0.8726M |
| December 31, 2019 | -0.4449M |
| September 30, 2019 | -2.167M |
| June 30, 2019 | -2.815M |
| March 31, 2019 | -4.706M |
| December 31, 2018 | -6.625M |
| September 30, 2018 | -4.646M |
| June 30, 2018 | -3.585M |
| March 31, 2018 | -2.013M |
| December 31, 2017 | -2.217M |
| September 30, 2017 | -2.011M |
| June 30, 2017 | -1.963M |
| March 31, 2017 | -1.673M |
| December 31, 2016 | -7.591M |
| September 30, 2016 | -3.526M |
| June 30, 2016 | -4.140M |
| March 31, 2016 | -3.128M |
| December 31, 2015 | -2.223M |
| September 30, 2015 | -3.080M |
| June 30, 2015 | -2.098M |
| March 31, 2015 | -1.387M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cibus, Inc. | -22.14M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| NovelStem International Corp. | -0.0858M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.188M |
| EPS Diluted (Quarterly) | -0.2064 |
| Enterprise Value | 35.22M |
| Earnings Yield | -620.5% |
| Normalized Earnings Yield | -600.16 |